Fundraising Fox

Soft Tissue Regeneration

New Haven, US · Delaware corporation · 3 employees on LinkedIn

Biotech

Founders & leadership

JW
Joseph W ReillyExecutive

Board

KD
Konstantine DrakonakisBoard director
MB
Michael B AronsonBoard director
RE
Richard EmmittBoard director
DW
Daniel WagnerBoard director
CH
Charles HartBoard director

Reported raises · per SEC filings

Form D private placements

$18M disclosed across 5 rounds · 2013–2021

▶$3.9MraisedJun 2021 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffery A. BairdExecutive Officer
  • Richard EmmittDirector
  • Paul HermesDirector
  • Kevin A RoccoExecutive Officer, Director
  • Sacha LevyDirector
  • Daniel WagnerDirector
  • Nicholas PachudaDirector
Offering amount
$5M
Amount sold
$3.9M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2020 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Levy SachaDirector
  • Kevin A. RoccoExecutive Officer, Director
  • Paul HermesDirector
  • Richard EmmittDirector
  • Daniel WagnerDirector
Offering amount
$3.5M
Amount sold
$3.5M
Proceeds to insiders
$166.7K
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard EmmittDirector
  • Daniel WagnerDirector
  • Konstantine DrakonakisDirector
  • Kevin A RoccoExecutive Officer, Director
  • Paul HermesDirector
Offering amount
$1.8M
Amount sold
$1.4M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2016 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin RoccoExecutive Officer, Director
  • Daniel WagnerDirector
  • Konstantine DrakonakisDirector
  • Richard EmmittDirector
Offering amount
$2M
Amount sold
$1.5M
Minimum investment
$25K
Proceeds to insiders
$150K
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.7MraisedNov 2015 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Konstantine DrakonakisDirector
  • Charles HartDirector
  • Michael B AronsonDirector
  • Joseph W ReillyExecutive Officer, Director, Promoter
  • Richard EmmittDirector
  • Daniel WagnerDirector
Offering amount
$8.5M
Amount sold
$7.7M
Proceeds to insiders
$750K
First sale
Nov 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Soft Tissue Regeneration Raises Series C Financing and Rebrands to Biorezprweb.com · Mar 2017

Frequently asked questions

How much funding has Soft Tissue Regeneration raised?
Soft Tissue Regeneration has disclosed $18M raised across 5 rounds.
Where is Soft Tissue Regeneration headquartered?
Soft Tissue Regeneration is headquartered in New Haven, US.